推进转移性非小细胞肺癌患者的精准靶向治疗。
Advancing Precision-Targeted Treatment for Patients With Metastatic Non-Small Cell Lung Cancer.
作者信息
Bradley Tajuana, Sandy Beth
机构信息
From Georgia Cancer Specialists, affiliated with Northside Hospital Cancer Institute, Lawrenceville, Georgia.
Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
出版信息
J Adv Pract Oncol. 2024 Apr;15(3):170-176. doi: 10.6004/jadpro.2024.15.3.7. Epub 2024 Apr 1.
At JADPRO Live 2023, presenters discussed the implications of biomarker testing, pivotal clinical trials leading to recent FDA approvals, and evidence-based best practices for monitoring and managing adverse events associated with molecular targeted and combination therapies for patients with metastatic non-small cell lung cancer.
在2023年JADPRO直播活动中，演讲者们讨论了生物标志物检测的意义、促成近期美国食品药品监督管理局（FDA）批准的关键临床试验，以及针对转移性非小细胞肺癌患者监测和管理与分子靶向治疗及联合治疗相关不良事件的循证最佳实践。
Zotero 插件